adma elisa
angiotensin ii assay
Antibodies
Assay Kits
Biology Cells
cDNA
Clia Kits
Culture Cells
Devices
DNA
DNA Templates
DNA Testing
Elisa Kits
Enzymes
Equipments
Exosomes
fbxl2 antibody
Gels
gliadin elisa
gp91 antibody
icoslg antibody
il24 elisa
il5 elisa
Isotypes
iws1 antibody
Medium & Serums
NATtrol
Panel
Particles
PCR
Pcr Kits
Peptides
procollagen elisa
Reagents
Recombinant Proteins
Ria Kits
RNA
Test Kits
Vector & Virus
Western Blot
Dysfunctional glia: contributors to neurodegenerative disorders
Astrocytes are integral elements of the central nervous system, the place they’re concerned in quite a few features crucial for neuronal growth and functioning, together with upkeep of blood-brain barrier, formation of synapses, supporting neurons with vitamins and trophic elements, and defending them from harm. These roles are markedly affected in the midst of continual neurodegenerative issues, typically earlier than the onset of the illness. On this overview, we summarize the current findings supporting the speculation that astrocytes play a elementary position within the processes contributing to neurodegeneration. We deal with α-synucleinopathies and tauopathies as the commonest neurodegenerative illnesses.
The mechanisms implicated within the growth and development of those issues seem to not be solely neuronal, however are sometimes associated to the astrocytic-neuronal integrity and the response of astrocytes to the altered microglial perform. A profound understanding of the multifaceted features of astrocytes and identification of their communication pathways with neurons and microglia in well being and within the illness is of crucial significance for the event of novel mechanism-based therapies towards neurodegenerative issues. Data of lipid droplets (LDs) has developed from easy depots of lipid storage to dynamic and functionally energetic organelles concerned in a wide range of mobile features. Research have now knowledgeable vital roles for LDs in mobile signaling, metabolic illness, and irritation.
Whereas lipid droplet biology has been nicely explored in peripheral organs such because the liver and coronary heart, LDs inside the mind are comparatively understudied. The presence and performance of those dynamic organelles within the central nervous system has just lately gained consideration, particularly within the context of neurodegeneration. On this overview, we summarize the present understanding of LDs inside the mind, with an emphasis on their relevance in neurodegenerative illnesses.
Intercourse-dependent impact of APOE on Alzheimer’s illness and different age-related neurodegenerative issues
The significance of apolipoprotein E (APOE) in late-onset Alzheimer’s illness (LOAD) has been firmly established, however the mechanisms via which it exerts its pathogenic results stay elusive. As well as, the sex-dependent results of APOE on LOAD danger and endophenotypes have but to be defined. On this Overview, we revisit the completely different facets of APOE involvement in neurodegeneration and neurological illnesses, with explicit consideration to intercourse variations within the contribution of APOE to LOAD susceptibility.
We talk about the position of APOE in a broader vary of age-related neurodegenerative illnesses, and summarize the organic elements linking APOE to intercourse hormones, drawing on supportive findings from rodent fashions to determine main mechanistic themes underlying the exacerbation of LOAD-associated neurodegeneration and pathology within the feminine mind. Moreover, we checklist sex-by-genotype interactions recognized throughout neurodegenerative illnesses, proposing APOE variants as a shared etiology for intercourse variations within the manifestation of those illnesses. Lastly, we current current developments in ‘omics’ applied sciences, which give a brand new platform for extra in-depth investigations of how dysregulation of this gene impacts the event and development of neurodegenerative illnesses. Collectively, the proof summarized on this Overview highlights the interaction between APOE and intercourse as a key issue within the etiology of LOAD and different age-related neurodegenerative illnesses.
We emphasize the significance of cautious examination of intercourse as a contributing consider learning the underpinning genetics of neurodegenerative illnesses basically, however significantly for LOAD. Neurodegenerative issues have been proven to exhibit substantial interconnectedness with circadian rhythmicity. Alzheimer’s sufferers exhibit excessive degradation of the suprachiasmatic nucleus (SCN), the central endogenous circadian timekeeper, and Parkinson’s sufferers have extremely disrupted peripheral clock gene expression. Disrupted sleep patterns are extremely evident in sufferers with neurodegenerative illnesses; fragmented sleep has been proven to have an effect on tau-protein accumulation in Alzheimer’s sufferers, and fast eye motion (REM) behavioral dysfunction is noticed in a big quantity of Parkinson’s sufferers.
Protecting position of anticancer medication in neurodegenerative issues: A drug repurposing strategy
The illness heterogeneity and little therapeutic progress in neurodegenerative illnesses justify the necessity for novel and efficient drug discovery approaches. Drug repurposing is an rising strategy that reinvigorates the classical drug discovery methodology by divulging new therapeutic makes use of of present medication. The frequent organic background and inverse tuning between most cancers and neurodegeneration give weight to the conceptualization of repurposing of anticancer medication as novel therapeutics. Many research can be found within the literature, which highlights the success story of anticancer medication as repurposed therapeutics.
 Cholera toxin antibody |
|||
| 20-CR18 | Fitzgerald | 1 ml | EUR 369 |
|
Description: Rabbit polyclonal Cholera toxin antibody |
|||
 Cholera Toxin Antibody |
|||
| abx021602-1mg | Abbexa | 1 mg | EUR 599 |
|
|||
|
Cholera Toxin Antibody |
|||
| abx021603-1mg | Abbexa | 1 mg | EUR 599 |
|
|||
|
Cholera Toxin Antibody |
|||
| abx021604-1mg | Abbexa | 1 mg | EUR 599 |
|
|||
|
Cholera Toxin Antibody |
|||
| abx021605-1mg | Abbexa | 1 mg | EUR 739 |
|
|||
|
Cholera Toxin Antibody |
|||
| abx021606-1mg | Abbexa | 1 mg | EUR 739 |
|
|||
|
Cholera Toxin Antibody |
|||
| abx021607-1mg | Abbexa | 1 mg | EUR 739 |
|
|||
|
Cholera Toxin Antibody |
|||
| abx021608-1mg | Abbexa | 1 mg | EUR 599 |
|
|||
|
Cholera Toxin Antibody |
|||
| abx021609-1mg | Abbexa | 1 mg | EUR 599 |
|
|||
 Cholera Toxin beta Antibody |
|||
| abx022951-1ml | Abbexa | 1 ml | EUR 578 |
|
|||
) Cholera toxin antibody (B subunit) |
|||
| 70-1001 | Fitzgerald | 100 ul | EUR 462 |
|
Description: Goat polyclonal cholera toxin antibody (B subunit) |
|||
 Cholera toxin from Vibrio Cholerae |
|||
| 01-511 | Sceti | 100ug | EUR 388 |
|
Description: The Cholera toxin from Vibrio Cholerae is available in Europe and for worldwide shipping via Gentaur. |
|||
 Rabbit polyclonal antibody for Cholera toxin |
|||
| 1614 | Virostat | 1 ml | EUR 321.88 |
|
Description: This is HRP conjugated rabbit polyclonal antibody against Cholera toxin B subunit for WB, ELISA. |
|||
 Cholera Toxin Subunit B, CF488A conjugate |
|||
| 00070 | Biotium | 100ug | EUR 261 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
 Cholera Toxin Subunit B, CF568 conjugate |
|||
| 00071 | Biotium | 100ug | EUR 261 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
 Cholera Toxin Subunit B, CF594 conjugate |
|||
| 00072 | Biotium | 100ug | EUR 261 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
 Cholera Toxin Subunit B, CF640R conjugate |
|||
| 00073 | Biotium | 100ug | EUR 264 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
 Cholera Toxin Subunit B, CF532 conjugate |
|||
| 00074 | Biotium | 100ug | EUR 264 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
 Cholera Toxin Subunit B, CF543 conjugate |
|||
| 00075 | Biotium | 100ug | EUR 264 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
 Cholera Toxin Subunit B, CF620R conjugate |
|||
| 00076 | Biotium | 100ug | EUR 264 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
 Cholera Toxin Subunit B, CF633 conjugate |
|||
| 00077 | Biotium | 100ug | EUR 264 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
 Cholera Toxin Subunit B, CF660R conjugate |
|||
| 00078 | Biotium | 100ug | EUR 264 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
 Cholera Toxin Subunit B, CF680R conjugate |
|||
| 00079 | Biotium | 100ug | EUR 282 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
 Purified Cholera Toxin protein; vaccine grade |
|||
| AV-9135-1000 | Alpha Diagnostics | 1 mg | EUR 651 |
|
Purified Cholera Toxin protein; vaccine grade |
|||
| AV-9135-500 | Alpha Diagnostics | 500 ug | EUR 347 |
 Rabbit Anti-Cholera Toxin protein antiserum |
|||
| CTOX11-S | Alpha Diagnostics | 100 ul | EUR 457 |
) Purified Cholera Toxin protein (antigen grade) |
|||
| CTOX15-N-1000 | Alpha Diagnostics | 1 mg | EUR 651 |
|
Purified Cholera Toxin protein (antigen grade) |
|||
| CTOX15-N-500 | Alpha Diagnostics | 500 ug | EUR 347 |
 Purified Cholera Toxin A Subunit protein |
|||
| CTOX16-N-100 | Alpha Diagnostics | 100 ug | EUR 347 |
|
Rabbit polyclonal antibody for Cholera toxin |
|||
| 7921 | Virostat | 1 ml | EUR 283.81 |
|
Description: This is rabbit polyclonal antibody against Cholera toxin B subunit for WB, ELISA. |
|||
|
Rabbit polyclonal antibody for Cholera toxin |
|||
| 7923 | Virostat | 1 ml | EUR 300.13 |
|
Description: This is FITC conjugated rabbit polyclonal antibody against Cholera toxin B subunit for WB, ELISA. |
|||
|
Rabbit polyclonal antibody for Cholera toxin |
|||
| 7927 | Virostat | 1 ml | EUR 300.13 |
|
Description: This is Biotin conjugated rabbit polyclonal antibody against Cholera toxin B subunit for WB, ELISA. |
|||
 Cholera toxin A subunit from Vibrio Cholerae |
|||
| 01-521 | Sceti | 50ug | EUR 388 |
|
Description: The Cholera toxin A subunit from Vibrio Cholerae is available in Europe and for worldwide shipping via Gentaur. |
|||
 Cholera toxin B subunit from Vibrio Cholerae |
|||
| 01-525 | Sceti | 50ug | EUR 388 |
|
Description: The Cholera toxin B subunit from Vibrio Cholerae is available in Europe and for worldwide shipping via Gentaur. |
|||
 Mouse Anti Cholera Toxin Alpha Monoclonal Antibody |
|||
| DMABT-51164MC | Creative Diagnostics | 0.2 mg | EUR 710 |
 Rabbit Anti Cholera Toxin Polyclonal Antibody,HRP |
|||
| DPBT-66825RC | Creative Diagnostics | 1 ml | EUR 881 |
 Rabbit Anti Cholera Toxin Beta Polyclonal Antibody |
|||
| DPBT-66826RC | Creative Diagnostics | 1 ml | EUR 715 |
 Goat Anti-Cholera Toxin A subunit antiserum |
|||
| CTOX16-S | Alpha Diagnostics | 100 ul | EUR 457 |
 protein) Purified Cholera Toxin B Subunit (Choleragenoid) protein |
|||
| CTOX25-N-1000 | Alpha Diagnostics | 100 ug | EUR 286 |
 Rabbit Anti-Cholera Toxin B subunit antiserum |
|||
| CTOX25-S | Alpha Diagnostics | 100 ul | EUR 457 |
 Rabbit Anti-Cholera Toxin B subunit IgG |
|||
| CTOX26-A | Alpha Diagnostics | 100 ul | EUR 408 |
 Monoclonal Anti-Cholera Toxin B subunit IgG |
|||
| CTOX27-M | Alpha Diagnostics | 100 ug | EUR 482 |
 Mouse antibody for Cholera toxin B subunit |
|||
| 7953 | Virostat | 100 ug | EUR 321.88 |
|
Description: This is purified Mouse monoclonal antibody against Cholera toxin B subunit for WB, ELISA. |
|||
|
Mouse antibody for Cholera toxin B subunit |
|||
| 7954 | Virostat | 100 ug | EUR 321.88 |
|
Description: This is purified Mouse monoclonal antibody against Cholera toxin B subunit for WB, ELISA. |
|||
|
Mouse antibody for Cholera toxin B subunit |
|||
| 7955 | Virostat | 100 ug | EUR 321.88 |
|
Description: This is purified Mouse monoclonal antibody against Cholera toxin B subunit for WB, ELISA. |
|||
 Mouse Anti-Cholera Toxin A monoclonal antibody |
|||
| CABT-BL8726 | Creative Diagnostics | 1.0 mg | EUR 845 |
 Rabbit Anti Cholera Toxin Beta Polyclonal Antibody,FITC |
|||
| DPBT-66824RC | Creative Diagnostics | 1 ml | EUR 767 |
 Mouse anti Cholera Toxin B Subunit Monoclonal Antibody |
|||
| DCAB-TJ086 | Creative Diagnostics | 1 mg | EUR 955 |
 Purified Cholera Toxin protein control for Western Blot |
|||
| CTOX11-C | Alpha Diagnostics | 100 ul | EUR 286 |
 antiserum) Goat Anti-Cholera Toxin B subunit (Choleragenoid) antiserum |
|||
| CTOX28-S | Alpha Diagnostics | 100 ul | EUR 457 |
 Mouse Anti-Vibrio Cholera Toxin B monoclonal antibody |
|||
| CABT-BL8728 | Creative Diagnostics | 1.0 mg | EUR 845 |
) Mouse monoclonal anti-Cholera Toxin A IgG (Clone #1) |
|||
| CTOX16-M | Alpha Diagnostics | 100 ug | EUR 482 |
 Purified Cholera Toxin A subunit protein control for Western Blot |
|||
| CTOX16-C | Alpha Diagnostics | 100 ul | EUR 286 |
 Purified Cholera Toxin B subunit protein control for Western Blot |
|||
| CTOX27-C | Alpha Diagnostics | 100 ul | EUR 286 |
 Human Anti-Cholera Toxin B IgA ELISA kit, 96 tests, Quantitative |
|||
| 945-100-CTA | Alpha Diagnostics | 1 Kit | EUR 773 |
 Human Anti-Cholera Toxin B IgG ELISA kit, 96 tests, Quantitative |
|||
| 945-110-CTG | Alpha Diagnostics | 1 Kit | EUR 773 |
 Human Anti-Cholera Toxin B IgM ELISA kit, 96 tests, Quantitative |
|||
| 945-120-CTM | Alpha Diagnostics | 1 Kit | EUR 773 |
 Mouse Anti-Cholera Toxin B IgA ELISA kit, 96 tests, Quantitative |
|||
| 945-130-CTA | Alpha Diagnostics | 1 Kit | EUR 773 |
 Mouse Anti-Cholera Toxin B IgG ELISA kit, 96 tests, Quantitative |
|||
| 945-140-CTG | Alpha Diagnostics | 1 Kit | EUR 773 |
 Mouse Anti-Cholera Toxin B IgM ELISA kit, 96 tests, Quantitative |
|||
| 945-150-CTM | Alpha Diagnostics | 1 Kit | EUR 773 |
; 100 ug Diphtheria Toxin (#AV-9120-25);Diphtheria Toxin and 500 ug cholera toxin (#AV-9135-25;)) Bacterial endotoxins Combo Pak-1 (contains 25 ug Tetanus toxoid (#AV-9105-25); 100 ug Diphtheria Toxin (#AV-9120-25);Diphtheria Toxin and 500 ug cholera toxin (#AV-9135-25;) |
|||
| AV-9200-PK-1 | Alpha Diagnostics | 1 pk | EUR 773 |
 Mouse Anti Cholera Haemolysin Monoclonal Antibody |
|||
| DMABT-51163MC | Creative Diagnostics | 0.2 mg | EUR 710 |
 Antibody) Vibrio cholerae Haemolysin (Cholera HlyA) Antibody |
|||
| abx411680-02mg | Abbexa | 0.2 mg | EUR 565 |
|
|||
 HC Toxin |
|||
| 2728-1000 | Biovision | EUR 370 | |
|
HC Toxin |
|||
| 2728-500 | Biovision | EUR 229 | |
 Diphtheria toxin |
|||
| 01-517 | Sceti | 200ug | EUR 283 |
|
Description: The Diphtheria toxin is available in Europe and for worldwide shipping via Gentaur. |
|||
 Pertussis Toxin |
|||
| B7273-.05 | ApexBio | 50 µg | EUR 440 |
|
Description: Protein-based AB5-type exotoxin Pertussis toxin (PT) is produced by the bacterium Bordetella pertussis. PT can cause whooping cough.In vitro: PT has the effect on innate immune response. |
|||
|
Pertussis Toxin |
|||
| HY-112779 | MedChemExpress | 50ug | EUR 681 |
 Toxin GaTx1 |
|||
| H-6678.0100 | Bachem | 0.1mg | EUR 323 |
|
Description: Sum Formula: C147H224N46O47S9; CAS# [1926163-15-6] net |
|||
|
Toxin GaTx1 |
|||
| H-6678.0500 | Bachem | 0.5mg | EUR 1205 |
|
Description: Sum Formula: C147H224N46O47S9; CAS# [1926163-15-6] net |
|||
|
Toxin GaTx1 |
|||
| H-6678.1000 | Bachem | 1.0mg | EUR 2026 |
|
Description: Sum Formula: C147H224N46O47S9; CAS# [1926163-15-6] net |
|||
 Diphtheria toxin antibody |
|||
| 10R-D113a | Fitzgerald | 100 ug | EUR 349 |
|
Description: Mouse monoclonal Diphtheria toxin antibody |
|||
|
Diphtheria toxin antibody |
|||
| 10R-D113b | Fitzgerald | 100 ug | EUR 273 |
|
Description: Mouse monoclonal Diphtheria toxin antibody |
|||
|
Diphtheria toxin antibody |
|||
| 10R-D113c | Fitzgerald | 1 mg | EUR 367 |
|
Description: Mouse monoclonal Diphtheria toxin antibody |
|||
|
Diphtheria toxin antibody |
|||
| 10R-D113d | Fitzgerald | 1 mg | EUR 349 |
|
Description: Mouse monoclonal Diphtheria toxin antibody |
|||
|
Diphtheria toxin antibody |
|||
| 10C-CR9006M1 | Fitzgerald | 100 ug | EUR 506 |
|
Description: Mouse monoclonal Diphtheria toxin antibody |
|||
|
Diphtheria toxin antibody |
|||
| 10C-CR9006M2 | Fitzgerald | 100 ug | EUR 506 |
|
Description: Mouse monoclonal Diphtheria toxin antibody |
|||
 Tetanus toxin antibody |
|||
| 10-1558 | Fitzgerald | 1 mg | EUR 392 |
|
Description: Mouse monoclonal Tetanus toxin antibody |
|||
|
Tetanus toxin antibody |
|||
| 10-1559 | Fitzgerald | 1 mg | EUR 392 |
|
Description: Mouse monoclonal Tetanus toxin antibody |
|||
|
Diphtheria toxin antibody |
|||
| 10-D08A | Fitzgerald | 100 ug | EUR 241 |
|
Description: Mouse monoclonal Diphtheria toxin antibody |
|||
|
Diphtheria toxin antibody |
|||
| 10-D08B | Fitzgerald | 100 ug | EUR 308 |
|
Description: Mouse monoclonal Diphtheria toxin antibody |
|||
|
Diphtheria toxin antibody |
|||
| 10-D08C | Fitzgerald | 1 mg | EUR 358 |
|
Description: Mouse monoclonal Diphtheria toxin antibody |
|||
 Shiga Toxin antibody |
|||
| 10-E09D | Fitzgerald | 1 mg | EUR 273 |
|
Description: Mouse Monoclonal Shiga Toxin antibody |
|||
 Pasteurella multocida toxin |
|||
| 01-507 | Sceti | 50ug | EUR 492 |
|
Description: The Pasteurella multocida toxin is available in Europe and for worldwide shipping via Gentaur. |
|||
 Clostridium perfringens toxin |
|||
| 01-509 | Sceti | 50ug | EUR 492 |
|
Description: The Clostridium perfringens toxin is available in Europe and for worldwide shipping via Gentaur. |
|||
 T-2 Toxin |
|||
| AT057 | Unibiotest | 1mg | EUR 1114 |
 T2 Toxin [OVA] |
|||
| DAGA-013O | Creative Diagnostics | 500ul | EUR 845 |
 T2 Toxin [RPE] |
|||
| DAGA-013P | Creative Diagnostics | 125ul | EUR 1235 |
 Toxin zeta Antibody |
|||
| 1-CSB-PA363578LA01SMF | Cusabio |
|
|
|
|||
|
Description: A polyclonal antibody against Toxin zeta. Recognizes Toxin zeta from Streptococcus agalactiae. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
 Tetanus Toxin Antibody |
|||
| abx021633-1mg | Abbexa | 1 mg | EUR 690 |
|
|||
|
Tetanus Toxin Antibody |
|||
| abx021634-1mg | Abbexa | 1 mg | EUR 690 |
|
|||
|
Tetanus Toxin Antibody |
|||
| abx021635-1mg | Abbexa | 1 mg | EUR 690 |
|
|||
 Diphtheria Toxin Antibody |
|||
| abx021657-1mg | Abbexa | 1 mg | EUR 599 |
|
|||
|
Diphtheria Toxin Antibody |
|||
| abx021658-1mg | Abbexa | 1 mg | EUR 599 |
|
|||
|
Diphtheria Toxin Antibody |
|||
| abx021659-1mg | Abbexa | 1 mg | EUR 599 |
|
|||
|
Diphtheria Toxin Antibody |
|||
| abx021660-1mg | Abbexa | 1 mg | EUR 1156 |
|
|||
|
Diphtheria Toxin Antibody |
|||
| abx021664-1mg | Abbexa | 1 mg | EUR 565 |
|
|||
 Tetanus toxin Peptide |
|||
| 20-abx266461 | Abbexa |
|
|
|
|||
 Tetanus Toxin Peptide |
|||
| abx670083-50ug | Abbexa | 50 ug | EUR 286 |
|
|||
|
T-2 Toxin |
|||
| AG057 | Unibiotest | 1 mg | EUR 438 |
) Rabbit Anti-C. tetani purified toxin IgG (tetanus shock toxin) |
|||
| TTOX12-A | Alpha Diagnostics | 100 ul | EUR 408 |
) Monoclonal Anti-C. tetani purified toxin IgG (tetanus shock toxin) |
|||
| TTOX14-M | Alpha Diagnostics | 100 ug | EUR 482 |
 Bordetella pertussis toxin protein |
|||
| 30-1855 | Fitzgerald | 1 mg | EUR 2115 |
|
Description: Purified Native Bordetella pertussis toxin protein |
|||
|
Bordetella pertussis toxin protein |
|||
| 30-1856 | Fitzgerald | 200 ug | EUR 654 |
|
Description: Purified Native Bordetella pertussis toxin protein |
|||
 Clostridium botulinum Toxin antibody |
|||
| 20C-CR7002R | Fitzgerald | 1 ml | EUR 136 |
|
Description: Rabbit polyclonal Clostridium botulinum Toxin antibody |
|||
 Diphtheria toxin mutant CRM197 |
|||
| 01-515 | Sceti | 200ug | EUR 283 |
|
Description: The Diphtheria toxin mutant CRM197 is available in Europe and for worldwide shipping via Gentaur. |
|||
 Staphylococcal Alpha – Toxin P1 |
|||
| 5-01961 | CHI Scientific | 4 x 5mg | Ask for price |
 peptide) Tetanus toxin (TT) peptide |
|||
| 5-02005 | CHI Scientific | 4 x 5mg | Ask for price |
 Streptococcus agalactiae Toxin zeta |
|||
| 1-CSB-EP363578SMF | Cusabio |
|
|
|
|||
|
Description: Recombinant Streptococcus agalactiae Toxin zeta expressed in E.coli |
|||
 T-2 Toxin [HRP] |
|||
| DAGA-013H | Creative Diagnostics | 1mg | EUR 1105 |
 T-2 Toxin [KLH] |
|||
| DAGA-015K | Creative Diagnostics | 1mg | EUR 1014 |
 T-2 Toxin [BSA] |
|||
| DAGHZ07 | Creative Diagnostics | 1mg | EUR 780 |
|
Streptococcus agalactiae Toxin zeta |
|||
| 1-CSB-YP363578SMF | Cusabio |
|
|
|
|||
|
Description: Recombinant Streptococcus agalactiae Toxin zeta expressed in Yeast |
|||
 KP6 killer toxin Antibody |
|||
| 1-CSB-PA325875LA01UBC | Cusabio |
|
|
|
|||
|
Description: A polyclonal antibody against KP6 killer toxin. Recognizes KP6 killer toxin from Ustilago maydis P6 virus. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
 Diphtheria Toxin / Toxoid Antibody |
|||
| abx022966-1ml | Abbexa | 1 ml | EUR 578 |
|
|||
 Shiga Toxin 2b Antibody |
|||
| abx023825-1mg | Abbexa | 1 mg | EUR 1094 |
|
|||
 C.Difficile Toxin A Antibody |
|||
| abx023921-1mg | Abbexa | 1 mg | EUR 878 |
|
|||
|
Diphtheria Toxin / Toxoid Antibody |
|||
| abx021665-1mg | Abbexa | 1 mg | EUR 1017 |
|
|||
 Bordetella Pertussis Toxin Antibody |
|||
| abx411171-02mg | Abbexa | 0.2 mg | EUR 565 |
|
|||
 Chlolera Toxin Beta Antibody |
|||
| abx411214-1ml | Abbexa | 1 ml | EUR 509 |
|
|||
 Antibody) Diphtheria Toxin (tox) Antibody |
|||
| abx411295-01mg | Abbexa | 0.1 mg | EUR 592 |
|
|||
 Diphtheria Toxin A Antibody |
|||
| abx411296-01mg | Abbexa | 0.1 mg | EUR 606 |
|
|||
|
Diphtheria Toxin (tox) Antibody |
|||
| abx411297-1ml | Abbexa | 1 ml | EUR 509 |
|
|||
 Chlolera Toxin Alpha Antibody |
|||
| abx411678-02mg | Abbexa | 0.2 mg | EUR 565 |
|
|||
|
Chlolera Toxin Beta Antibody |
|||
| abx411679-02mg | Abbexa | 0.2 mg | EUR 565 |
|
|||
 Antibody) Toxin B (toxB) Antibody |
|||
| 20-abx319421 | Abbexa |
|
|
|
|||
 Antibody) Toxin A (toxA) Antibody |
|||
| 20-abx319425 | Abbexa |
|
|
|
|||
|
KP6 killer toxin Antibody |
|||
| 20-abx319880 | Abbexa |
|
|
|
|||
 Antibody) Tetanus Toxin (TETX) Antibody |
|||
| 20-abx300499 | Abbexa |
|
|
|
|||
 Toxin Zeta Polyclonal Antibody |
|||
| A55034 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: Ask the seller for details |
|||
 T-2 Toxin Standard |
|||
| SD012 | Unibiotest | 0.5ug/mL | EUR 607 |
 HT-2 Toxin Standard |
|||
| SD014 | Unibiotest | 0.5ug/mL | EUR 607 |
 Inactivated Bordetella Pertussis Toxin |
|||
| VAng-Lsx2691-50g | Creative Biolabs | 50 µg | EUR 1208 |
|
Description: Bordetella Pertussis toxin, native Protein. |
|||
) Vibrio cholerae serotype O1 Cholera enterotoxin subunit B (ctxB) |
|||
| 1-CSB-EP360704VEX | Cusabio |
|
|
|
|||
|
Description: Recombinant Vibrio cholerae serotype O1 Cholera enterotoxin subunit B(ctxB) expressed in E.coli |
|||
) Monoclonal Anti-C. tetani purified toxin/toxoid IgG (tetanus shock toxin) |
|||
| TTOX13-M | Alpha Diagnostics | 100 ul | EUR 482 |
) G. Pig anti-C. tetani purified toxin IgG (tetanus shock toxin) |
|||
| TTOX15-S | Alpha Diagnostics | 100 ul | EUR 457 |
 Clostridium difficile Toxin A protein |
|||
| 30-1863 | Fitzgerald | 10 ug | EUR 1961 |
|
Description: Purified Native Clostridium difficile Toxin A protein (ribotype 027) |
|||
 Clostridium difficile Toxin B protein |
|||
| 30-1864 | Fitzgerald | 10 ug | EUR 2252 |
|
Description: Purified Native Clostridium difficile Toxin B protein (ribotype 027) |
|||
|
Clostridium difficile Toxin A protein |
|||
| 30-1865 | Fitzgerald | 10 ug | EUR 2349 |
|
Description: Purified Native Clostridium difficile Toxin A protein (ribotype 078) |
|||
|
Clostridium difficile Toxin B protein |
|||
| 30-1866 | Fitzgerald | 10 ug | EUR 2638 |
|
Description: Purified Native Clostridium difficile Toxin B protein (ribotype 078) |
|||
 C. difficile Toxin A protein |
|||
| 30-1985 | Fitzgerald | 100 ug | EUR 967 |
|
Description: Clostridium difficile Toxin A protein |
|||
 Clostridium difficile Toxin A antibody |
|||
| 70-1004 | Fitzgerald | 500 ul | EUR 486 |
|
Description: Goat polyclonal Clostridium difficile Toxin A antibody |
|||
|
Clostridium difficile Toxin A antibody |
|||
| 70-1005 | Fitzgerald | 100 ug | EUR 755 |
|
Description: Affinity purified Chicken polyclonal Clostridium difficile Toxin A antibody |
|||
 Clostridium difficile toxin B antibody |
|||
| 70-1017 | Fitzgerald | 100 ug | EUR 755 |
|
Description: Affinity purified chicken polyclonal Clostridium difficile toxin B antibody |
|||
 Shiga toxin subunit B Antibody |
|||
| 48147-100ul | SAB | 100ul | EUR 333 |
|
Shiga toxin subunit B Antibody |
|||
| 48147-50ul | SAB | 50ul | EUR 239 |
 Clostridum difficile toxin A antibody |
|||
| 10-1273a | Fitzgerald | 1 mg | EUR 696 |
|
Description: Mouse monoclonal Clostridum difficile toxin A antibody |
|||
|
Clostridium difficile toxin B antibody |
|||
| 10-1274 | Fitzgerald | 1 mg | EUR 873 |
|
Description: Mouse monoclonal Clostridium difficile toxin B antibody |
|||
|
Clostridium difficile toxin B antibody |
|||
| 10-1276 | Fitzgerald | 1 mg | EUR 989 |
|
Description: Mouse monoclonal Clostridium difficile toxin B antibody |
|||
|
Clostridum difficile toxin A antibody |
|||
| 10-1492 | Fitzgerald | 200 ug | EUR 289 |
|
Description: Mouse monoclonal Clostridum difficile toxin A antibody |
|||
|
Clostridum difficile toxin A antibody |
|||
| 10-1493 | Fitzgerald | 200 ug | EUR 337 |
|
Description: Mouse monoclonal Clostridum difficile toxin A antibody |
|||
|
Clostridum difficile toxin A antibody |
|||
| 10-C67A | Fitzgerald | 200 ug | EUR 337 |
|
Description: Mouse monoclonal Clostridum difficile toxin A antibody |
|||
|
Clostridum difficile toxin A antibody |
|||
| 10-C67B | Fitzgerald | 200 ug | EUR 337 |
|
Description: Mouse monoclonal Clostridum difficile toxin A antibody |
|||
 Clostridum difficile toxin B antibody |
|||
| 10-C67C | Fitzgerald | 200 ug | EUR 404 |
|
Description: Mouse monoclonal Clostridum difficile toxin B antibody |
|||
|
Clostridum difficile toxin B antibody |
|||
| 10-C67D | Fitzgerald | 200 ug | EUR 404 |
|
Description: Mouse monoclonal Clostridum difficile toxin B antibody |
|||
|
Clostridum difficile toxin B antibody |
|||
| 10-C67E | Fitzgerald | 200 ug | EUR 337 |
|
Description: Mouse monoclonal Clostridum difficile toxin B antibody |
|||
Amongst them, kinase inhibitors, developed for numerous oncology indications evinced notable neuroprotective results in neurodegenerative illnesses. On this overview, we make clear the salient position of a number of protein kinases in neurodegenerative issues. We additionally proposed a possible clarification of the motion of kinase inhibitors in neurodegenerative issues with extra consideration in the direction of neurodegenerative issues. The issue of neurotoxicity related to some anticancer medication can also be highlighted. Our overview encourages additional analysis to raised encode the hidden potential of anticancer medication with the goal of growing potential repurposed medication with no toxicity for neurodegenerative issues.